111 related articles for article (PubMed ID: 15136484)
1. A pilot evaluation of micrometastases for the prediction of outcome in lung cancer.
Thompson AB; Kessinger A; Sharp JG
Chest; 2004 May; 125(5 Suppl):156S-7S. PubMed ID: 15136484
[No Abstract] [Full Text] [Related]
2. Does bone marrow involvement affect prognosis in small-cell lung cancer?
Pasini F; Cetto GL; Pelosi G
Ann Oncol; 1998 Mar; 9(3):247-50. PubMed ID: 9602256
[No Abstract] [Full Text] [Related]
3. Effects of different immunolabeling techniques on the detection of small-cell lung cancer cells in bone marrow.
Pelosi G; Pasini F; Pavanel F; Bresaola E; Schiavon I; Iannucci A
J Histochem Cytochem; 1999 Aug; 47(8):1075-88. PubMed ID: 10424892
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum levels of soluble interleukin-2 receptors in lung cancer and the effect of surgery.
Chan CH; Ho J; Lai CK; Leung JC; Lai KN
Respir Med; 1993 Jul; 87(5):383-5. PubMed ID: 8209059
[No Abstract] [Full Text] [Related]
5. Bone marrow micrometastases in advanced stage non-small cell lung carcinoma patients.
Brunsvig PF; Flatmark K; Aamdal S; Høifødt H; Le H; Jakobsen E; Sandstad B; Fodstad O
Lung Cancer; 2008 Aug; 61(2):170-6. PubMed ID: 18261824
[TBL] [Abstract][Full Text] [Related]
6. [The use of monoclonal antibodies in the detection of small cell lung cancer metastases in bone marrow].
Obłakowski P; Pacuszka T; Rogińska E; Remiszewski P; Załeska J; Zych J; Roszkowski K; Rowińska-Zakrzewska E
Pneumonol Alergol Pol; 1999; 67(1-2):53-9. PubMed ID: 10481525
[TBL] [Abstract][Full Text] [Related]
7. [Usefulness of carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA), enolase (NSE) and thymidine-kinase (TK) in the monitoring and prognosis of primary carcinoma of the lung].
De Angelis G; De Marinis F; Bigioni D; Migliorino MR; Alma MG; Pigorini F
J Nucl Med Allied Sci; 1990; 34(4 Suppl):135-40. PubMed ID: 1965445
[No Abstract] [Full Text] [Related]
8. Clinical significance of micrometastasis in lung and esophageal cancer: a new paradigm in thoracic oncology.
Jiao X; Krasna MJ
Ann Thorac Surg; 2002 Jul; 74(1):278-84. PubMed ID: 12118789
[TBL] [Abstract][Full Text] [Related]
9. [Is hyponatremia a prognostic marker of survival for lung cancer?].
Petereit C; Zaba O; Teber I; Grohé C
Pneumologie; 2011 Sep; 65(9):565-71. PubMed ID: 21837588
[TBL] [Abstract][Full Text] [Related]
10. [Detection of small cell lung cancer metastases in the bone marrow in vitro using monoclonal antibodies].
Goncharskaia MA; Orel NF; Perevodchikova NI; Solov'eva EA
Biull Eksp Biol Med; 1996 Apr; 121(4):456-8. PubMed ID: 8829467
[No Abstract] [Full Text] [Related]
11. [Prognostic factors in unresectable lung cancer].
Urata A
Gan To Kagaku Ryoho; 1988 Jul; 15(7):2035-42. PubMed ID: 2840034
[TBL] [Abstract][Full Text] [Related]
12. Detection of occult bone marrow micrometastases in patients with operable lung carcinoma.
Cote RJ; Beattie EJ; Chaiwun B; Shi SR; Harvey J; Chen SC; Sherrod AE; Groshen S; Taylor CR
Ann Surg; 1995 Oct; 222(4):415-23; discussion 423-5. PubMed ID: 7574923
[TBL] [Abstract][Full Text] [Related]
13. High plasma D-dimer level is associated with decreased survival in patients with lung cancer.
Altiay G; Ciftci A; Demir M; Kocak Z; Sut N; Tabakoglu E; Hatipoglu ON; Caglar T
Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):494-8. PubMed ID: 17513096
[TBL] [Abstract][Full Text] [Related]
14. Occult micrometastasis to bone marrow in early lung cancer: a clinicopathologic study from West Bengal, India.
Biswas S; Sarkar S; Chakraborty J; Chakrabarti S
Asian Pac J Cancer Prev; 2010; 11(3):747-51. PubMed ID: 21039047
[TBL] [Abstract][Full Text] [Related]
15. CYFRA 21-1 as a tool for distant metastasis detection in lung cancer.
Cabrera-Alarcon JL; Carrillo-Vico A; Santotoribio JD; Leon-Justel A; Sanchez-Gil R; Gonzalez-Castro A; Guerrero JM
Clin Lab; 2011; 57(11-12):1011-4. PubMed ID: 22239035
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-13 expression is associated with bone marrow microinvolvement and prognosis in non-small cell lung cancer.
Hsu CP; Shen GH; Ko JL
Lung Cancer; 2006 Jun; 52(3):349-57. PubMed ID: 16569461
[TBL] [Abstract][Full Text] [Related]
17. Small-cell lung cancer and elevated CA 19.9 tumor marker levels.
Prieto De Paula JM; Mayor Toranzo E; Gallardo Borge L; Franco Hidalgo S
Arch Bronconeumol; 2012 Oct; 48(10):385-6. PubMed ID: 22555288
[No Abstract] [Full Text] [Related]
18. Invited commentary.
Grannis F
Ann Thorac Surg; 2006 Jan; 81(1):297. PubMed ID: 16368384
[No Abstract] [Full Text] [Related]
19. Bone marrow metastasis of small cell carcinoma of the lung mimicking Burkitt lymphoma/leukaemia.
Iguchi T; Awaya N; Kobayashi K; Okamoto S
Br J Haematol; 2005 Sep; 130(5):652. PubMed ID: 16115119
[No Abstract] [Full Text] [Related]
20. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T
Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
